ATE386734T1 - Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivaten - Google Patents
Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivatenInfo
- Publication number
- ATE386734T1 ATE386734T1 AT04730128T AT04730128T ATE386734T1 AT E386734 T1 ATE386734 T1 AT E386734T1 AT 04730128 T AT04730128 T AT 04730128T AT 04730128 T AT04730128 T AT 04730128T AT E386734 T1 ATE386734 T1 AT E386734T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxy
- oxo
- acetonitrile
- pyran
- tetrahydro
- Prior art date
Links
- NUTZEIABCUGDLR-UHFFFAOYSA-N 2-(4-hydroxy-6-oxooxan-2-yl)acetonitrile Chemical compound OC1CC(CC#N)OC(=O)C1 NUTZEIABCUGDLR-UHFFFAOYSA-N 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101227 | 2003-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386734T1 true ATE386734T1 (de) | 2008-03-15 |
Family
ID=33395971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04730128T ATE386734T1 (de) | 2003-05-02 | 2004-04-28 | Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivaten |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7423162B2 (de) |
| EP (1) | EP1620423B1 (de) |
| JP (1) | JP2006525323A (de) |
| KR (1) | KR20060011984A (de) |
| CN (2) | CN1780826B (de) |
| AT (1) | ATE386734T1 (de) |
| AU (1) | AU2004234308A1 (de) |
| BR (1) | BRPI0409866A (de) |
| CA (1) | CA2524457A1 (de) |
| CO (1) | CO5700715A2 (de) |
| CY (1) | CY1113498T1 (de) |
| DE (1) | DE602004011921T2 (de) |
| DK (1) | DK1620423T3 (de) |
| EA (1) | EA010100B1 (de) |
| ES (1) | ES2300769T3 (de) |
| IL (1) | IL171539A (de) |
| IS (1) | IS8159A (de) |
| NO (1) | NO20055694L (de) |
| NZ (1) | NZ543294A (de) |
| PL (1) | PL1620423T3 (de) |
| SI (1) | SI1620423T1 (de) |
| UA (1) | UA83662C2 (de) |
| WO (1) | WO2004096788A1 (de) |
| ZA (1) | ZA200508862B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2522656A3 (de) * | 2003-07-25 | 2013-03-20 | Redx Pharma Limited | Verfahren und Intermediate zur Herstellung von Statinen, insbesondere Atorvastatin |
| US7701550B2 (en) | 2004-08-19 | 2010-04-20 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
| DE102005022284A1 (de) * | 2005-05-13 | 2006-11-23 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen |
| US8047545B2 (en) * | 2007-11-07 | 2011-11-01 | Douglas Press, Inc. | Lottery-type game with rollover feature |
| US8404870B2 (en) * | 2008-01-23 | 2013-03-26 | Lek Pharmaceuticals D.D. | ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof |
| SI2614057T1 (sl) | 2010-09-09 | 2016-03-31 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Soli estrov 7-amino-3,5-dihidroksi heptanojske kisline |
| EP2616454B1 (de) * | 2010-09-16 | 2015-04-15 | DSM Sinochem Pharmaceuticals Netherlands B.V. | Hexansäureester als zwischenprodukte zur herstellung von atorvastatin |
| CN105669637A (zh) * | 2014-11-21 | 2016-06-15 | 南京博优康远生物医药科技有限公司 | 一种3,5,6-取代己酸酯衍生物的制备方法 |
| CN112501223B (zh) * | 2020-11-23 | 2022-08-12 | 江苏阿尔法药业股份有限公司 | 制备2-((2r，4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法 |
| CN116102482A (zh) * | 2022-08-17 | 2023-05-12 | 重庆普佑生物医药有限公司 | 一种阿托伐他汀钙的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5097045A (en) * | 1989-02-01 | 1992-03-17 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| US5003080A (en) | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
| NL1015744C2 (nl) * | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
| AU2003263031A1 (en) * | 2002-09-20 | 2004-04-08 | Diversa Corporation | Chemoenzymatic methods for the synthesis of statins and stain intermediates |
-
2004
- 2004-04-28 KR KR1020057020818A patent/KR20060011984A/ko not_active Withdrawn
- 2004-04-28 DK DK04730128T patent/DK1620423T3/da active
- 2004-04-28 AT AT04730128T patent/ATE386734T1/de active
- 2004-04-28 BR BRPI0409866-8A patent/BRPI0409866A/pt not_active IP Right Cessation
- 2004-04-28 WO PCT/NL2004/000284 patent/WO2004096788A1/en not_active Ceased
- 2004-04-28 CN CN2004800117927A patent/CN1780826B/zh not_active Expired - Fee Related
- 2004-04-28 SI SI200430673T patent/SI1620423T1/sl unknown
- 2004-04-28 DE DE602004011921T patent/DE602004011921T2/de not_active Expired - Lifetime
- 2004-04-28 CN CN201010111364.9A patent/CN101775000B/zh not_active Expired - Fee Related
- 2004-04-28 EA EA200501734A patent/EA010100B1/ru not_active IP Right Cessation
- 2004-04-28 UA UAA200511372A patent/UA83662C2/ru unknown
- 2004-04-28 NZ NZ543294A patent/NZ543294A/en unknown
- 2004-04-28 JP JP2006507876A patent/JP2006525323A/ja not_active Withdrawn
- 2004-04-28 EP EP04730128A patent/EP1620423B1/de not_active Expired - Lifetime
- 2004-04-28 ES ES04730128T patent/ES2300769T3/es not_active Expired - Lifetime
- 2004-04-28 CA CA002524457A patent/CA2524457A1/en not_active Abandoned
- 2004-04-28 AU AU2004234308A patent/AU2004234308A1/en not_active Abandoned
- 2004-04-28 US US10/554,294 patent/US7423162B2/en not_active Expired - Fee Related
- 2004-04-28 PL PL04730128T patent/PL1620423T3/pl unknown
-
2005
- 2005-10-23 IL IL171539A patent/IL171539A/en active IP Right Grant
- 2005-11-01 ZA ZA200508862A patent/ZA200508862B/xx unknown
- 2005-11-02 CO CO05111845A patent/CO5700715A2/es not_active Application Discontinuation
- 2005-11-30 IS IS8159A patent/IS8159A/is unknown
- 2005-12-01 NO NO20055694A patent/NO20055694L/no not_active Application Discontinuation
-
2008
- 2008-05-13 CY CY20081100505T patent/CY1113498T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA83662C2 (ru) | 2008-08-11 |
| PL1620423T3 (pl) | 2008-07-31 |
| DK1620423T3 (da) | 2008-05-26 |
| DE602004011921T2 (de) | 2009-02-19 |
| EP1620423B1 (de) | 2008-02-20 |
| SI1620423T1 (sl) | 2008-06-30 |
| EA010100B1 (ru) | 2008-06-30 |
| DE602004011921D1 (de) | 2008-04-03 |
| CO5700715A2 (es) | 2006-11-30 |
| WO2004096788A1 (en) | 2004-11-11 |
| BRPI0409866A (pt) | 2006-05-16 |
| IL171539A (en) | 2011-03-31 |
| NO20055694D0 (no) | 2005-12-01 |
| IS8159A (is) | 2005-11-30 |
| CN1780826B (zh) | 2010-05-26 |
| CN101775000A (zh) | 2010-07-14 |
| AU2004234308A1 (en) | 2004-11-11 |
| CN101775000B (zh) | 2014-09-24 |
| NO20055694L (no) | 2006-02-02 |
| CA2524457A1 (en) | 2004-11-11 |
| CY1113498T1 (el) | 2016-06-22 |
| JP2006525323A (ja) | 2006-11-09 |
| ES2300769T3 (es) | 2008-06-16 |
| KR20060011984A (ko) | 2006-02-06 |
| EA200501734A1 (ru) | 2006-04-28 |
| EP1620423A1 (de) | 2006-02-01 |
| US20060258733A1 (en) | 2006-11-16 |
| NZ543294A (en) | 2008-05-30 |
| ZA200508862B (en) | 2007-02-28 |
| US7423162B2 (en) | 2008-09-09 |
| CN1780826A (zh) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004030239D1 (de) | Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon | |
| WO2004029045A3 (en) | Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof | |
| ATE481987T1 (de) | Verfahren zur radiofluoridierung von biologisch aktiven vektoren | |
| MY142029A (en) | Phenoxyacetic acid derivatives | |
| TW200519106A (en) | Organic compounds | |
| PL377838A1 (pl) | Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy | |
| ATE302786T1 (de) | Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv | |
| DE502004004681D1 (de) | Verfahren zur herstellung von salzen schwach koordinierender aniomen, derartige salze sowie deren verwendung | |
| MY148297A (en) | Process for modifying drug crystal formation | |
| CY1113498T1 (el) | Διαδικασια για την παρασκευη (4-υδροξυ-6-οξο-τετραϋδροπυραν-2-υλ) ακετονιτριλιου και παραγωγων αυτου | |
| DE60038560D1 (de) | Verfahren zur fermentativen Herstellung von L-Arginin | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| IL157046A0 (en) | Phthalic acid diamide, method for the production thereof and the use of the same as a pesticide | |
| DE602004025935D1 (de) | Histondeacetylaseinhibitor und verfahren zu dessen herstellung | |
| EP1944027A4 (de) | Pharmazeutische zusammensetzung zur behandlung oder prävention von nephritis und herstellungsverfahren dafür | |
| ATE466010T1 (de) | Verfahren zur herstellung von candesartan | |
| DE502004006253D1 (de) | Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung | |
| ATE515502T1 (de) | Verfahren zur herstellung von tetranorlabdanderivaten | |
| ATE451367T1 (de) | Verfahren zur herstellung von ziprasidon | |
| DE60327567D1 (de) | Verfahren zur herstellung von 3,3',4,4'-tetraaminobiphenyl | |
| DE60225338D1 (de) | Verfahren zur herstellung von derivaten von 3,3-dimethyl-2-formylcyclopropanekarbonsäure | |
| ATE250581T1 (de) | Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin | |
| DE60332384D1 (de) | Verfahren zur herstellung von 1,5-diaminonaphthalin | |
| DE602005018770D1 (de) | Verfahren zur herstellung von 1,5-diphenylpyrazolcarbonsäurederivaten | |
| TH87425B (th) | ไพริมิดีนที่ถูกแทนที่ด้วยไดอะมิโน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1620423 Country of ref document: EP |